The European Commission (EC) has authorised Celltrion’s COVID-19 monoclonal antibody (mAb) treatment Regkirona (regdanvimab, CT-P59), the company announced yesterday.
The European Medicines Agency (EMA)’s human medicines committee, the Committee for Medicinal Products for Human Use (CHMP), has recommended authorising Ronapreve™ ...